A clinical trial has found that antiviral drug remdesivir reduces serious outcomes and hospitalization in unvaccinated high-risk COVID-19 patients, if administered in the early stages of their ...

Researchers have finally published the data that led the federal government to recommend the use of the antiviral drug remdesivir in very ill coronavirus patients, and they say the drug alone will not ...

Remdesivir, an experimental antiviral drug from Gilead Sciences, has shown promise based on early results in people with severe COVID-19, the disease caused by the new coronavirus. But experts caution ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Gilead Sciences Inc. said it is recalling tens of thousands of vials of ...

The COVID-19 treatment remdesivir dominated hospital drug spending in 2021, accounting for nearly 10% of all pharmaceutical expenses and outpacing the next three drugs combined, according to the ...

The antiviral drug remdesivir can help keep unvaccinated people at risk of severe covid-19 out of hospitals, according to a study that found the treatment reduced hospitalization and death by 87 ...

Jan. 22 (UPI) --The Food and Drug Administration has expanded its authorization of the antiviral drug remdesivir to some COVID-19 outpatients. The FDA took two actions Friday to expand the use of the ...

Certain vials of remdesivir, an antiviral COVID-19 drug, are being recalled over glass shards, according to a recent recall notice. Biopharmaceutical company Gilead announced the recall of 55,000 ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Federal regulators Friday approved the use of the antiviral drug remdesivir for covid-19 outpatients at high risk of being hospitalized, providing a new treatment option for doctors struggling with ...